FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Imprimis NJOF Dexamethasone Moxifloxacin Ketorolac Recall

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0

Imprimis NJOF, LLC · Ledgewood, NJ

Risk level
Class II
Reported by FDA
Jan 14, 2026
Recall ID
D-0250-2026
Check your lot numberHow we source this data

Summary

Imprimis NJOF recalled Dexamethasone Moxifloxacin Ketorolac starting Dec 18, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0250-2026 on Jan 14, 2026. Reason: Presence of particulate matter - Glass like particles. Status: Ongoing.

Why it was recalled

Presence of particulate matter - Glass like particles.

Product description

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.

Lot numbers, UPCs & expiration codes

Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.

Where it was sold

U.S Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0250-2026
Classification
Class II
Status
Ongoing
Recall initiated
Dec 18, 2025
FDA report date
Jan 14, 2026
Quantity
596 boxes of 11,920 pre-filled syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Imprimis NJOF, LLC

Original FDA data

Every field from FDA enforcement report D-0250-2026, exactly as published.

Show all FDA fields
City
Ledgewood
State
NJ
Status
Ongoing
Country
United States
Event ID
98181
Address
1705 Route 46 Ste 6B
Code information
Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.
Postal code
07852-9720
Report date
Jan 14, 2026
Product type
Drugs
Recall number
D-0250-2026
Classification
Class II
Recalling firm
Imprimis NJOF, LLC
Product quantity
596 boxes of 11,920 pre-filled syringes
Reason for recall
Presence of particulate matter - Glass like particles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Distribution pattern
U.S Nationwide
Recall initiation date
Dec 18, 2025
Initial firm notification
Letter
Center classification date
Jan 2, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0250-2026, published Jan 14, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls